429 related articles for article (PubMed ID: 31638645)
1. Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease.
Ruiz HH; Ramasamy R; Schmidt AM
Endocrinology; 2020 Jan; 161(1):. PubMed ID: 31638645
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Pertynska-Marczewska M; Merhi Z
Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
[TBL] [Abstract][Full Text] [Related]
3. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
4. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
7. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
8. Role of advanced glycation end products and insulin resistance in diabetic nephropathy.
Parwani K; Mandal P
Arch Physiol Biochem; 2023 Feb; 129(1):95-107. PubMed ID: 32730131
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products and insulin resistance.
Unoki H; Yamagishi S
Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review.
Mouanness M; Nava H; Dagher C; Merhi Z
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079834
[TBL] [Abstract][Full Text] [Related]
11. Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments.
Wasim R; Mahmood T; Siddiqui MH; Ahsan F; Shamim A; Singh A; Shariq M; Parveen S
Life Sci; 2022 Oct; 307():120860. PubMed ID: 35940220
[TBL] [Abstract][Full Text] [Related]
12. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
[TBL] [Abstract][Full Text] [Related]
13. Receptor for the Advanced Glycation End Products (
Gutowska K; Czajkowski K; Kuryłowicz A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446161
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
15. The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction.
Sergi D; Boulestin H; Campbell FM; Williams LM
Mol Nutr Food Res; 2021 Jan; 65(1):e1900934. PubMed ID: 32246887
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
18. Dietary natural products as a potential inhibitor towards advanced glycation end products and hyperglycemic complications: A phytotherapy approaches.
M V; Wang K
Biomed Pharmacother; 2021 Dec; 144():112336. PubMed ID: 34678719
[TBL] [Abstract][Full Text] [Related]
19. Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation.
Mastrocola R; Collotta D; Gaudioso G; Le Berre M; Cento AS; Ferreira Alves G; Chiazza F; Verta R; Bertocchi I; Manig F; Hellwig M; Fava F; Cifani C; Aragno M; Henle T; Joshi L; Tuohy K; Collino M
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32824970
[TBL] [Abstract][Full Text] [Related]
20. Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products.
Li L; Song Q; Zhang X; Yan Y; Wang X
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
